首页|解毒复正合剂的提取工艺优化及指纹图谱研究

解毒复正合剂的提取工艺优化及指纹图谱研究

扫码查看
目的 优化解毒复正合剂的水提工艺,建立质量标准及指纹图谱对其化学成分进行鉴定。方法 采用正交试验方法,L9(34)试验设计考察加水量、提取次数、提取时间等因素对提取工艺的影响,优选解毒复正合剂的水提工艺;采用HPLC法建立其含量测定方法,同时建立其指纹图谱,以黄芩苷、橙皮苷总含量,出膏率及总黄酮含量为综合评价指标。结果 确定解毒复正合剂最佳水提工艺是以10倍水,煎煮3次,每次1。5h;紫外分光光度法结果显示,解毒复正合剂总黄酮平均含量为33。423μg/ml,HPLC结果显示,黄芩苷、橙皮苷平均总含量为771。971μg/ml。结论 该研究为解毒复正合剂水提工艺的确定提供了依据,建立的质量标准也能稳定的控制其有效物质成分,为后续研究打下了基础。
Optimization of extraction process and fingerprint analysis of detoxifying and revitalizing agents
Objective To optimize the water extraction process of detoxification and rejuvenating mixture,and establish quality standards and fingerprints to identify its chemical composition.Methods The orthogonal test method and L9(34)experimental de-sign were used to investigate the effects of water addition,extraction times,extraction time and other factors on the extraction process,and the water extraction process of the detoxification and renormalization mixture was optimized.The content determina-tion method was established by HPLC method,and the fingerprint was established,and the total content of baicalin,hesperidin,ointment yield and total flavonoids were used as comprehensive evaluation indexes.Results The best water extraction process was determined to be 10 times of water,decoction for 3 times,each time for 1.5h,ultraviolet spectrophotometry results showed that the average content of total flavonoids of detoxification and rejuvenating mixture was 33.423 μg/ml,and HPLC results showed that the average total content of baicalin and hesperidin was 771.971 μg/ml.Conclusion This study provides a basis for the determi-nation of the water extraction process of detoxification and rejuvenating mixture,and the established quality standard can also stab-ly control its active substance composition,which lays a foundation for subsequent research.

Jiedu Fuzheng mixtureExtraction processFingerprint

苏倩榕、梁芬兰、姚菲、柳子扬、王超、杨正腾

展开 >

广西中医药大学,广西南宁 530200

广西高校中药制剂共性技术研发重点实验室,广西南宁 530200

广西中医药大学第一附属医院,广西南宁 530023

解毒复正合剂 提取工艺 指纹图谱

广西科技基地和人才专项国家自然科学基金地区基金广西壮瑶药重点实验室课题

2023AC1400582260956GXZYKF2022-12

2024

时珍国医国药
时珍国医国药杂志社

时珍国医国药

北大核心
影响因子:0.887
ISSN:1008-0805
年,卷(期):2024.35(6)